Cigna Group $CI Stock Purchased by TD Waterhouse Canada Inc.

Key Points

• TD Waterhouse Canada increased its Cigna stake by 15.6% in the third quarter, adding 5,803 shares to hold 43,077 shares valued at approximately $11.71 million.
• Cigna reported quarterly earnings of $7.78 per share, beating estimates of $7.60, while revenue rose 6.7% year over year to $71.56 billion. The company also announced a quarterly dividend of $1.56, equivalent to a 2.1% annualized yield.
• Analysts maintain a “Moderate Buy” consensus on Cigna, with 15 Buy and eight Hold ratings and an average price target of $338.24, compared with the stock’s reported price of $302.48.

TD Waterhouse Canada Inc. boosted its stake in shares of Cigna Group (NYSE:CI - Free Report) by 15.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 43,077 shares of the health services provider's stock after buying an additional 5,803 shares during the period. TD Waterhouse Canada Inc.'s holdings in Cigna Group were worth $11,710,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Osbon Capital Management LLC purchased a new position in shares of Cigna Group in the second quarter worth approximately $26,000. Cedar Mountain Advisors LLC raised its holdings in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after acquiring an additional 68 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $29,000. Fiduciary Financial Advisors purchased a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $29,000. Finally, ANTIPODES PARTNERS Ltd acquired a new position in Cigna Group in the 2nd quarter worth approximately $34,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Price Performance

NYSE CI opened at $302.48 on Monday. The company has a 50 day simple moving average of $278.87 and a 200-day simple moving average of $281.99. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The firm has a market capitalization of $79.93 billion, a price-to-earnings ratio of 12.51, a price-to-earnings-growth ratio of 1.02 and a beta of 0.29. Cigna Group has a 52-week low of $239.51 and a 52-week high of $311.34.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $71.56 billion during the quarter, compared to analysts' expectations of $70.14 billion. During the same period last year, the company posted $7.20 earnings per share. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts predict that Cigna Group will post 30.50 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were given a $1.56 dividend. The ex-dividend date was Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group's dividend payout ratio is presently 25.82%.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company's stock, valued at $1,435,304.65. This trade represents a 10.88% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of Cigna Group stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the sale, the insider directly owned 25,880 shares of the company's stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 22,730 shares of company stock valued at $6,293,359. Insiders own 0.60% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on CI. Guggenheim lifted their price objective on shares of Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Jefferies Financial Group lowered Cigna Group from a "buy" rating to a "hold" rating and reduced their target price for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Barclays increased their target price on Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. Piper Sandler set a $370.00 target price on Cigna Group and gave the stock an "overweight" rating in a research report on Friday, October 2nd. Finally, Evercore assumed coverage on Cigna Group in a report on Wednesday, September 9th. They set an "in-line" rating and a $290.00 price target on the stock. Fifteen analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $338.24.

Cigna Group Company Profile

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.